Evaluation of fibroblast activation protein-specific PET/CT in a patient with post-COVID pneumonitis
Musameh K, O'Brien S, Mehboob R, Butler T, Cunningham Z, Buckley C, Atzinger A, Kuwert T, Mitchell P, Donnelly SC (2024)
Publication Type: Journal article
Publication year: 2024
Journal
Book Volume: 12
Article Number: e01446
Journal Issue: 9
DOI: 10.1002/rcr2.1446
Abstract
Coronavirus disease 2019 (COVID-19) often leads to a spectrum of pulmonary complications, including interstitial lung disease (ILD) with the potential for fibrotic sequelae. Assessing the presence of ongoing active inflammation versus established residual fibrosis as a result of lung parenchymal injury and repair in these patients is a clinical challenge. Better understanding of the disease process is crucial for guiding appropriate therapeutic strategies. We aim to investigate the use of positron emission tomography / computer tomography (PET/CT) scans and their role in diagnosing interstitial pneumonitis (IP) post COVID infections.
Authors with CRIS profile
Involved external institutions
Ireland (IE)How to cite
APA:
Musameh, K., O'Brien, S., Mehboob, R., Butler, T., Cunningham, Z., Buckley, C.,... Donnelly, S.C. (2024). Evaluation of fibroblast activation protein-specific PET/CT in a patient with post-COVID pneumonitis. Respirology Case Reports, 12(9). https://doi.org/10.1002/rcr2.1446
MLA:
Musameh, Khaled, et al. "Evaluation of fibroblast activation protein-specific PET/CT in a patient with post-COVID pneumonitis." Respirology Case Reports 12.9 (2024).
BibTeX: Download